Table 1.

Demographic summary of the paediatric patients treated with Anti-Mycobacterial Antibiotic Therapy (AMAT) (n = 16).

Characteristics	Value
Age and Sex
Age at commencement (mean)	14.2
Males (n)	11
Previous Treatment
Previous treatment (n)	14
Previous immunosuppressive treatment (n)	12
AMAT Drugs (n) and Dosage (${\mathsf{\sigma }}_{\overline{x}}$ Max Dose mg/kg/d) used in Combination
Rifabutin	16 (10.9 ± 0.7)
Clarithromycin	15 (26.4 ± 2.1)
Clofazimine	16 (2.4 ± 0.2)
Metronidazole	8 (8.7 ± 0.6)
Ciprofloxacin	8 (32.5 ± 4.6)